About the Company
We do not have any company description for ENZO BIOCHEM INC at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ENZ News
Enzo Biochem Inc ENZ
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Here's Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)
Laughing Water Capital featured stocks such as Enzo Biochem, Inc. (NYSE:ENZ) in the fourth quarter 2023 investor letter. Headquartered in Farmingdale, New York, Enzo Biochem, Inc. (NYSE ...
Enzo Biochem gets grant for method for detecting enzymes adding functional groups to compounds
Detect and quantify chemically modified compounds with Enzo Biochem Inc's patented method. Learn how to isolate compounds with functional groups for precise research and diagnostic applications.
Enzo Biochem (NYSE: ENZ)
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable ...
Enzo Biochem: Fiscal Q2 Earnings Snapshot
FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Wednesday reported a loss of $3.1 million in its fiscal second quarter. The Farmingdale, New York-based company ...
Enzo Biochem Reports 2008 Fiscal First Quarter Results
Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications ...
Enzo Biochem, Inc. (ENZ)
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31 ...
Enzo Biochem, Inc. (ENZ)
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31 ...
Enzo Biochem Inc.
In this interview, Dr. Church, the Molecular and Pediatric Pathologist at Boston Children's Hospital, talks to NewsMedical about their work in pediatric oncology, and the need to expand research ...
Enzo Biochem Inc ENZ
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Enzo Biochem Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...